Zacks Buy List Highlights: Sciele Pharma, Inc., The Boeing Company, ZOLL Medical Corporation and Imperial Sugar Company.

CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today are Sciele Pharma, Inc. (Nasdaq: SCRX), The Boeing Company (NYSE: BA), ZOLL Medical Corporation (Nasdaq: ZOLL), and Imperial Sugar Company (Nasdaq: IPSU).

Stocks ranked #1 (Strong Buy) by Zacks have produced an average annual return of +31.8% since inception in 1988. During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8% while the S&P 500 tumbled 37.6%. To see the full Zacks #1 Rank (Strong Buy) List, or the rank for any other stock, visit: http://at.zacks.com/?id=88

Here is a synopsis of today's Zacks Rank Buy Stocks:

Aggressive Growth - Sciele Pharma, Inc. (Nasdaq: SCRX)

Sciele Pharma, Inc. has met or exceeded earnings estimates in 12 out of the past 13 quarters. Year-over-year growth has consistently been above 30% over that time period. Three analysts have raised their forecasts for this year, while seven have done so for next year. Earnings estimates for 2007 have increased a solid 16 cents to $1.57 per share over the past 90 days. The stock is trading at a reasonable 15.4x 2007 earnings.

Growth & Income - The Boeing Company (NYSE: BA)

The Boeing Company, which was first introduced as a Growth and Income stock on Apr 11, beat analysts' earnings expectations in 14 out of the past 15 quarters. On Dec 11, the Board of Directors announced a 17% increase in its quarterly dividend to 35 cents per share. The company has a current dividend yield of 1.4% and a five-year average dividend yield 1.7%. BA's return on equity tops that of the industry average--15% compared to 12%.

Momentum - ZOLL Medical Corporation (Nasdaq: ZOLL)

ZOLL Medical Corporation was first highlighted as a Zacks Momentum Stock of the Day on Jun 13, 2006. Since that time the stock has gained 92%. ZOLL is expected to report first-quarter fiscal 2007 earnings on Jan 25. Analysts are expecting profits of 19 cents per share, up 58% from the same quarter last year. Can ZOLL deliver a positive earnings surprise in light of such an increase? History would certainly seem to be on the company's side, which includes a run of positive earnings surprises the last five quarters in a row.

Value - Imperial Sugar Company (Nasdaq: IPSU)

Imperial Sugar Company, a Zacks #1 Rank stock, exceeded analysts' earnings expectations in three out of the past four quarters by an average of 150.0%. Consensus estimates for both this quarter and for the full year have risen considerably over the past two months. The Board of Directors recently declared a special dividend of $3.00 per share in mid December. The company has a price-to-book ratio of 1.6, compared to 4.8 for the market.

Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report, "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions," provides an insightful background about this wealth-building tool. Download your free copy of the report now to prosper in the years to come by visiting http://at.zacks.com/?id=93.

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." A $10,000 investment in the Zacks Rank list made in 1988 would now be worth $1.77 million - equivalent to a 31.8% annualized return! During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8%, while the S&P 500 tumbled 37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 143.6% annually (+4.8% vs. +11.8%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=90.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=91

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(a) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.